Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)

MMWR Morb Mortal Wkly Rep. 2007 Oct 19;56(41):1080-4.


In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged > or =2 years. In 2005, vaccine manufacturers received Food and Drug Administration approval for use of the vaccines in children aged 12-23 months.

Publication types

  • Practice Guideline

MeSH terms

  • Hepatitis A / prevention & control*
  • Hepatitis A / transmission
  • Hepatitis A Vaccines / administration & dosage*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Travel*


  • Hepatitis A Vaccines
  • Immunoglobulins, Intravenous